Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $(0.13) by 576.92 percent. This is a 100 percent increase over earnings of $0.31 per share from the same period last year. The company reported quarterly sales of $467.172 million which beat the analyst consensus estimate of $409.297 million by 14.14 percent. This is a 40.79 percent increase over sales of $331.817 million the same period last year.